Q&A with Christopher Sealey of CoverUS

CoverUS currently projects a $1.8 billion yearly market share (SOM), as we endeavor to be the largest and best source of highly qualified patient leads across three primary verticals: market research, clinical trials, and the marketing of health goods and services. By keeping patients financially well, we also tackle the problem of non-adherence to prescriptions, which currently costs the global pharmaceutical industry more than $637 billion per year. Engaging data-connected patients at scale with their consent can unlock massive future revenue opportunities across all facets of a healthcare industry that currently wastes $1 trillion per year in the United States alone. The CoverUS solution is not only a marketplace play, but our privacy standards and technology are a welcome hedge against increasingly stringent data privacy regulations that the healthcare industry is facing.

Our team is the right mix of successful entrepreneurs, healthcare and consumer marketing gurus, and engineering leaders. Our advisory board includes the current CEO of Planned Parenthood, the former Chief Technology Officer of the United States Health and Human Services Department, and the former Chief Financial Officer and Chief Information Officer of Covance, one of the largest clinical trials companies in the world. People that would not normally support an early-stage health tech startup are all in on CoverUS.

CoverUS has raised early money from prominent Angel investors, delivered on that investment by developing an app prototype that is currently enjoying an extremely successful pilot with 300+ real patients, earning and saving money in the app. We are poised to demonstrate further product-market fit and acquire pre-identified top talent at below-market prices upon closing its $2.5 million seed round, which has already received a $500,000 commitment from a world renowned computer scientist. Our current $10 million valuation is conservative, and we are looking for skilled capital that wants to help drive a high growth, for-profit business while leaving a profound social legacy by helping to make healthcare more affordable for everyone, everywhere.